Spots Global Cancer Trial Database for gnrh agonist
Every month we try and update this database with for gnrh agonist cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases | NCT00079001 | Metastatic Canc... Prostate Cancer | zoledronic acid placebo androgen depriv... GnRH agonist Calcium supplem... Vitamin D | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients | NCT00417144 | Polycystic Ovar... Ovarian Hyperst... | Arvekap 0.1mg (... Ganirelix 0.25m... | 18 Years - 50 Years | Eugonia | |
| Hormone Therapy, Radiation Therapy, and Steroid 17alpha-monooxygenase TAK-700 in Treating Patients With High-Risk Prostate Cancer | NCT01546987 | Prostate Cancer | GnRH agonist Anti-androgen TAK-700 Radiation thera... | 18 Years - | Radiation Therapy Oncology Group | |
| Value of LNG-IUS as Fertility-preserving Treatment of EAH and EC | NCT03463252 | Endometrial Can... Atypical Endome... | Progesterone Mirena® GnRH agonist | - 40 Years | West China Second University Hospital | |
| Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases | NCT00079001 | Metastatic Canc... Prostate Cancer | zoledronic acid placebo androgen depriv... GnRH agonist Calcium supplem... Vitamin D | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Cardiovascular Events in GnRH Agonist vs. Antagonist | NCT04182594 | Hormone Sensiti... Prostate Cancer Cardiac Event | Degarelix GnRH agonist | 18 Years - 90 Years | Rabin Medical Center | |
| Effect of GnRH Agonist vs GnRH Antagonist on IVF/ICSI Outcomes in Polycystic Ovary Syndrome Patients. | NCT04727671 | In Vitro Fertil... Intracytoplasmi... Infertility Polycystic Ovar... | Triptorelin ace... Cetrorelix recombinant-FSH... Human Chorionic... | 18 Years - 39 Years | Damascus University | |
| Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer | NCT02799706 | Prostate Cancer | Degarelix approved GnRH a... Radiotherapy | 18 Years - 80 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Trial Comparing Irradiation Plus Long Term Adjuvant Androgen Deprivation With GnRH Antagonist Versus GnRH Agonist Plus Flare Protection in Patients With Very High Risk Localized or Locally Advanced Prostate Cancer | NCT02799706 | Prostate Cancer | Degarelix approved GnRH a... Radiotherapy | 18 Years - 80 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
| Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases | NCT00079001 | Metastatic Canc... Prostate Cancer | zoledronic acid placebo androgen depriv... GnRH agonist Calcium supplem... Vitamin D | 18 Years - | Alliance for Clinical Trials in Oncology | |
| Comparison Between GnRH Agonist and GnRH Antagonist Protocols of Ovarian Stimulation in PCOS Patients | NCT00417144 | Polycystic Ovar... Ovarian Hyperst... | Arvekap 0.1mg (... Ganirelix 0.25m... | 18 Years - 50 Years | Eugonia | |
| Intramuscular Mechanisms of Androgen Deprivation-related Sarcopenia | NCT03867357 | Metastatic Pros... Androgen Depriv... | GnRH agonist | 18 Years - 90 Years | Seattle Institute for Biomedical and Clinical Research | |
| A Study of Apalutamide Combined With GnRH Agonist in Participants With Androgen Receptor Positive Salivary Gland Carcinoma | NCT04325828 | Salivary Gland ... | Apalutamide GnRH Agonist | 18 Years - | Janssen Pharmaceutical K.K. | |
| INTREPId (INTermediate Risk Erection PreservatIon Trial) | NCT04025372 | Prostate Cancer | Bicalutamide GnRH Agonist Radiation Thera... Darolutamide | 18 Years - | Dana-Farber Cancer Institute |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
